Watch These Stocks: American Airlines Group (NASDAQ:AAL), General Electric Company (NYSE:GE), Johnson & Johnson (NYSE:JNJ), ServiceNow (NYSE:NOW)

Research Frontiers Inc. (NASDAQ:REFR) shares moved up 5.00% in last trading session and ended the day at $4.83. REFR has a return on assets of -39.80%. Research Frontiers Inc. (NASDAQ:REFR) quarterly performance is -0.41%.

Zacks Investment Research lowered shares of Research Frontiers, Inc. (NASDAQ:REFR) from a hold rating to a strong sell rating in a research note published on Wednesday, Market Beat Ratings reports.

On 15 March, American Airlines Group Inc. (NASDAQ:AAL) will enjoy an upgraded travel experience when the world’s largest airline introduces the newest addition to its fleet, the Boeing 787-8 Dreamliner, into service from Manchester Airport (MAN) to Chicago O’Hare International Airport (ORD).
American Airlines Group Inc. (NASDAQ:AAL) ended the last trading day at $43.47. Company weekly volatility is calculated as 1.97% and price to cash ratio as 2.95. American Airlines Group Inc. (NASDAQ:AAL) showed a weekly performance of 2.07%.

On 21 March, General Electric Company (NYSE:GE) shares advanced 0.55% and was closed at $31.09. GE EPS growth in last 5 year was -31.80%. General Electric Company (NYSE:GE) year to date (YTD) performance is 0.61%.

General Electric Company (NYSE:GE) declared a $0.23 per share dividend on the outstanding common stock of the Company payable April 25, 2016 to shareowners of record at the close of business on February 29, 2016. The ex-dividend date is February 25, 2016.

Johnson & Johnson (NYSE:JNJ) shares moved down -0.20% in last trading session and ended the day at $107.28. JNJ Gross Margin is 69.30% and its has a return on assets of 11.70%. Johnson & Johnson (NYSE:JNJ) quarterly performance is 4.26%.

Johnson & Johnson (NYSE:JNJ) said that, its wholly owned subsidiary Janssen Biotech, Inc. finalized an agreement to collaborate on research with Nextera AS, a privately held biotechnology company based in Oslo, Norway. The research deal centers around Nextera’s groundbreaking immunological technology platform, which is used in the development of specialized immunotherapies targeting autoimmune diseases, cancers and infections.

ServiceNow, Inc. (NYSE:NOW) caters to the Technology space. It has a net profit margin of -19.70% and weekly performance is -2.09%. On the last day of trading company shares ended up at $61.05. ServiceNow, Inc. (NYSE:NOW) distance from 50-day simple moving average (SMA50) is -2.22%.

On 9 March, ServiceNow, Inc. (NYSE:NOW) has settled its patent row with Hewlett-Packard. The financial details of the settlement were not disclosed. The agreement resolves all claims asserted by Hewlett-Packard.

Leave a Reply

Your email address will not be published. Required fields are marked *